PDF(Sci-hub)
Abstract：
An association between tyrosine-kinase inhibitor therapy for chronic myeloid leukemia and vascular adverse events including peripheral arterial disease, coronary artery disease, and pulmonary hypertension has been described. We present a patient who developed isolated pulmonary artery vasculitis resulting in left pulmonary artery stenosis, in addition to left coronary artery stenosis while on nilotinib. While monitoring for cardiovascular events is important, clinicians should also recognize possible drug-induced vasculitis during chronic nilotinib therapy.
摘要：
酪氨酸激酶抑制剂治疗慢性髓性白血病与血管不良事件（包括外周动脉疾病）之间的关联,冠状动脉疾病,和肺动脉高压已被描述。我们介绍了一名患者，其发展为孤立的肺动脉血管炎导致左肺动脉狭窄，除了在尼罗替尼时左冠状动脉狭窄。虽然监测心血管事件很重要，临床医师还应认识到慢性尼洛替尼治疗期间可能的药物性血管炎.
